FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 21, 2021

CANNABIS GLOBAL, INC.

(Exact Name of Registrant as Specified in its Charter)

520 S. Grand Avenue, Suite 320, Los Angeles, CA 90071

(Address of Principal Executive Offices and Zip Code) 

(310) 986-4929

(Issuer's telephone number)

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒ 

Item 7.01 Regulation FD Disclosure

Cannabis Global, Inc. (the “Company”) makes the following disclosures pursuant to Regulation FD, as executives with the Company plan to meet with institutional investors relative to the acquisition of growth capital.

Since acquiring a controlling interest in Natural Plant Extract (NPE), which operates a licensed cannabis manufacturing and distribution business in Lynwood, California, holding a Type 7 California Manufacturing and a distribution license, allowing for cannabis product distribution anywhere in the state, the Company has invested approximately $200,000 into NPE, with funds primarily targeted at launching new products under the Northern Lights brand name, settling past debts, and acquiring high-volume manufacturing equipment.

The Company has begun to receive orders for several product lines, which is ongoing with early customer deliveries occurring over the past few days. In addition, the Company has come to an agreement with a cannabis delivery service located in the area to provide distribution and others services relating to the distribution for brands offered to the delivery service’s customers.

As a result of this product production, contract manufacturing, and distribution activity, the Company expects an increase in revenues beginning on March 1, 2021, and ending on May 30, 2021. 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated April 21, 2021